MU
Insider
Marshall Urist
EVP, Research & InvestmentsMarshall Urist (EVP, Research & Investments) filed 14 Form 4 reports in the trailing twelve months (0 purchases, 14 sales), most often in Royalty Pharma plc (RPRX). The largest single filing was $1.7M of RPRX (41,575 sh across 2 lots, as filed), executed Dec 1 2025.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
14
0 buys · 14 sells
Median delay
–
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$12.1M
shares × price, as filed
Last traded
Jul 1
Filed Jul 2
Median ADV $206.7M across their filed names
Open performance→Volume by month
Buys $0
Sells $12.1M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
14 filings
Sector per market data · by filing · past 12 months
Most traded names
RPRXRecent filings
RPRXSALE
Royalty Pharma plc
View filing →
$508K9,099 sh × $55.88
Exec Jul 1
Filed Jul 2 · 4:10 PM ET RPRXSALE Royalty Pharma plc View filing → $502K
9,098 sh × $55.18
Exec Jun 24
Filed Jun 25 · 5:30 PM ET RPRXSALE Royalty Pharma plc View filing → $722K
13,684 sh × $52.75
Exec May 20
Filed May 21 · 5:30 PM ET RPRXSALE Royalty Pharma plc View filing → $726K
13,684 sh × $53.06
Exec May 14
Filed May 15 · 5:30 PM ET RPRXSALE Royalty Pharma plc View filing → $822K
20,000 sh × $41.09
Exec Jan 30
Filed Feb 2 · 5:30 PM ET RPRXSALE Royalty Pharma plc View filing → $805K
20,000 sh × $40.26
Exec Jan 23
Filed Jan 26 · 5:30 PM ET RPRXSALE Royalty Pharma plc View filing → $790K
20,000 sh × $39.52
Exec Jan 16
Filed Jan 20 · 5:30 PM ET RPRXSALE Royalty Pharma plc View filing → $816K
20,000 sh × $40.78
Exec Jan 9
Filed Jan 13 · 5:30 PM ET More filings →